NYSE:COR Cencora Q4 2026 Earnings Report $315.74 -1.51 (-0.48%) As of 11:44 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Cencora EPS ResultsActual EPSN/AConsensus EPS $4.57Beat/MissN/AOne Year Ago EPSN/ACencora Revenue ResultsActual RevenueN/AExpected Revenue$87.97 billionBeat/MissN/AYoY Revenue GrowthN/ACencora Announcement DetailsQuarterQ4 2026Date11/4/2026TimeBefore Market OpensConference Call DateWednesday, November 4, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Cencora Earnings HeadlinesLeerink Partners Adjusts Price Target on Cencora to $388 From $380October 7 at 12:27 PM | finance.yahoo.comCencora Insider Sold Shares Worth $298,935, According to a Recent SEC FilingOctober 6 at 9:17 AM | finance.yahoo.com$169 Private Jet Trick ExposedFor $169, a growing circle of travelers are booking private jets without the wait, the hassle, or the high price tag. Travel writer Jennifer Stevens reveals the trick in her new book, Secrets Travel Writers Never Share, packed with 101 ways to fly, dine and stay like a VIP for less, including $32 five-star hotel stays and $26 Michelin-star meals.October 8 at 1:00 AM | International Living (Ad)Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs GrowOctober 6 at 3:50 AM | seekingalpha.comTop Cencora Executive Makes Notable Insider Stock MoveOctober 5 at 10:10 PM | tipranks.comCencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings ReleaseOctober 2, 2026 | finance.yahoo.comSee More Cencora Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cencora? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cencora and other key companies, straight to your email. Email Address About CencoraCencora (NYSE:COR), formerly known as AmerisourceBergen, is a global pharmaceutical solutions company that sources, distributes and supports the delivery of medicines and healthcare products. The company serves pharmaceutical manufacturers, healthcare providers, pharmacies and animal-health customers through its supply-chain and commercialization services. Its activities include pharmaceutical and specialty-product distribution, manufacturer services, specialty logistics, clinical-trial support, patient-support programs and other services designed to help bring medicines to market and improve access to treatment. Cencora also provides animal-health products and services through its related businesses. Headquartered in Conshohocken, Pennsylvania, Cencora operates across the United States and international markets, including Europe and other regions. The company adopted the Cencora name in 2023 as part of its broader global identity. Robert P. Mauch serves as president and chief executive officer, while Steven H. Collis serves as executive chairman.View Cencora ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Skydance Just Became a Media Giant—With an $80 Billion Debt LoadConstellation Brands Beat Earnings, But Beer Demand Is Still a ProblemTesla's EV Delivery Beat Is In, So What Happens Now?BigBear.ai Is Heavily Shorted—and Its Fundamentals Are Starting to ChangePenguin Solutions Is Soaring as AI Memory Demand ExplodesDoes Lemonade’s Growth Signal Profits Ahead?Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run Upcoming Earnings Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
